SQD.V · SQI Diagnostics Inc

-

Please sign in to comment on SQD.V

1 Comment

Admin

3 years, 8 months ago

SQI Diagnostics Inc is currently in a long term downtrend where the price is trading 36.1% below its 200 day moving average.

From a valuation standpoint, the stock is 89.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 102.6.

SQI Diagnostics Inc's total revenue sank by 22.2% to $161K since the same quarter in the previous year.

Its net income has dropped by 84.6% to $-4M since the same quarter in the previous year.

Finally, its free cash flow grew by 27.4% to $-1M since the same quarter in the previous year.

Based on the above factors, SQI Diagnostics Inc gets an overall score of 2/5.

Industry	Diagnostics & Research
Sector	Healthcare
ISIN	CA78466B1085
CurrencyCode	CAD
Exchange	V

Dividend Yield	0.0%
Target Price	6
Beta	0.02
PE Ratio	None
Market Cap	20M

ABOUT

SQI Diagnostics Inc

SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, it offers microarray tests for protein and antibody testing workflow. The company was founded in 1999 and is headquartered in Toronto, Canada.

SQD.V · SQI Diagnostics Inc

-

SQI Diagnostics Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest SQI Diagnostics Inc using a moving average strategy